인공 혈관 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 용도별, 지역별, 경쟁별(2020-2030년)

The Global Vascular Graft Market was valued at USD 1.29 Billion in 2024 and is anticipated to reach USD 1.97 Billion by 2030, growing at a CAGR of 7.31% during the forecast period. The market is witnessing strong growth, primarily due to the increasing prevalence of vascular disorders such as peripheral artery disease (PAD), aneurysms, and coronary artery disease (CAD). These conditions, which involve the narrowing or blockage of blood vessels, can lead to critical complications like stroke, myocardial infarction, and limb ischemia, thereby necessitating surgical interventions using vascular grafts. Additionally, the rising volume of procedures such as coronary artery bypass grafting (CABG) and endovascular aneurysm repair (EVAR) has further supported demand. Vascular grafts play a crucial role in these surgeries by replacing or bypassing damaged blood vessels. Technological progress and product innovation are also advancing the market. For example, in May 2022, UC Davis received a USD 3 million grant from the California Institute for Regenerative Medicine to develop a next-generation vascular graft for hemodialysis patients. Such developments reflect the ongoing commitment of stakeholders to enhance the performance and longevity of grafts, which is expected to significantly boost market growth in the coming years.

Key Market Drivers

Increasing Prevalence of Cardiovascular Diseases

The global vascular graft market is primarily driven by the escalating incidence of cardiovascular conditions such as coronary artery disease, peripheral arterial disease, and aortic aneurysms. These diseases represent a growing health concern worldwide, largely attributed to sedentary lifestyles, unhealthy diets, and an aging population. As more individuals develop comorbidities like hypertension, diabetes, and obesity, the risk of cardiovascular events increases, fueling the need for surgical interventions involving vascular grafts. This surge in disease burden directly correlates with rising demand for procedures like CABG and EVAR, where vascular grafts are essential for restoring adequate blood flow. As a result, the demand for graft-based solutions is set to grow steadily, supporting overall market expansion.

Key Market Challenges

Stringent Regulatory Hurdles

A significant challenge in the vascular graft market lies in the rigorous regulatory landscape governing medical devices. Organizations such as the U.S. FDA and EMA mandate thorough evaluations to ensure the safety and efficacy of vascular grafts, including extensive clinical trials and quality testing. While such standards are crucial for safeguarding public health, they contribute to extended development timelines and higher compliance costs. This can be particularly burdensome for smaller firms with limited resources, ultimately restricting the pace of innovation and delaying patient access to new products. Additionally, the need to navigate varying regulatory frameworks across different countries complicates global product approvals and increases market entry barriers for manufacturers.

Key Market Trends

Technological Advancements

Continuous innovation in graft materials and design is a key trend shaping the vascular graft market. Advanced materials, such as bioengineered and tissue-engineered grafts, have significantly enhanced the safety and performance of these products by improving biocompatibility and reducing the risk of complications. Furthermore, grafts featuring anti-thrombogenic and anti-infective coatings are gaining traction, offering better outcomes in terms of long-term patency and infection prevention. These developments not only improve surgical success rates but also enable wider application of vascular grafts in complex procedures. As technologies evolve, next-generation grafts are expected to play a more prominent role in vascular surgeries, encouraging wider clinical adoption and contributing to market growth.

Key Market Players

• Abbott Laboratories
• Braun Melsungen AG
• Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• Cardinal Health (Cordis Corporation)
• Cook Medical
• Endologix Inc.
• Getinge Group
• LeMaitre Vascular Inc.
• Medtronic PLC
• Terumo Medical Corporation

Report Scope:

In this report, the Global Vascular Graft Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vascular Graft Market, By Product:

• Hemodialysis Access Graft Endovascular Stent Graft
• Peripheral Vascular Graft
• Coronary Artery By-pass Graft

Vascular Graft Market, By Drug Application:

• Aneurysms
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Diseases
• Other Applications

Vascular Graft Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vascular Graft Market.

Available Customizations:

Global Vascular Graft Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vascular Graft Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Hemodialysis Access Graft, Endovascular Stent Graft, Peripheral Vascular Graft, Coronary Artery By-pass Graft)
  • 5.2.2. By Application (Aneurysms, Kidney Failure, Vascular Occlusion, Coronary Artery Diseases, Other Applications)
  • 5.2.3. By Company (2024)
  • 5.2.4. By Region
• 5.3. Market Map

6. North America Vascular Graft Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vascular Graft Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Mexico Vascular Graft Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Canada Vascular Graft Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Vascular Graft Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Vascular Graft Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. Germany Vascular Graft Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Vascular Graft Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Vascular Graft Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Vascular Graft Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia-Pacific Vascular Graft Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vascular Graft Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Vascular Graft Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. South Korea Vascular Graft Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. Japan Vascular Graft Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Vascular Graft Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. South America Vascular Graft Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vascular Graft Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. Argentina Vascular Graft Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. Colombia Vascular Graft Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. Middle East and Africa Vascular Graft Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vascular Graft Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Saudi Arabia Vascular Graft Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. UAE Vascular Graft Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Abbott Laboratories
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Braun Melsungen AG
• 15.3. Becton, Dickinson and Company (Bard Peripheral Vascular Inc.)
• 15.4. Cardinal Health (Cordis Corporation)
• 15.5. Cook Medical
• 15.6. Endologix Inc.
• 15.7. Getinge Group
• 15.8. LeMaitre Vascular Inc.
• 15.9. Medtronic PLC
• 15.10. Terumo Medical Corporation.

16. Strategic Recommendation

17. About Us & Disclaimer